News

  • Oct152021

    The Hebrew University President’s Report 2020/21

    The annual report is now available with a wealth of information about the University’s progress.

    Read more
  • Oct122021

    Choosing the ‘Best’ Embryo in IVF

    Parents Can Now Select Embryos with Reduced Risk for Cancer and Mental Illness, But Does It Work?

    Read more
  • Oct122021

    Hebrew University Congratulates Former Faculty Member Joshua Angrist on Winning Nobel Prize in Economics

    The Hebrew University of Jerusalem (HU) heartily congratulates Professor Joshua Angrist and Guido Imbens, along with David Card, on being awarded the 2021 Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel.

    Read more
  • Oct082021

    Elucidating The Brain’s White Matter

    Novel Method Developed at Hebrew University Reveals Details of Nerve Connections in the Brain.

    Read more
  • Oct072021

    *Updated* When Archaic Homo Met Homo Sapiens

    ***Now with BBC Film*** New Fossils Reveal Interactions Between Ancient Human Groups Living Together in the Levant.

    Read more
  • Sep262021

    Hebrew University Professor named new head of the CERN Council

    CERN, the European Organization for Nuclear Research, is one of the world’s largest and most respected centres for scientific research.

    Read more
  • Sep142021

    FUTURE magazine 2021/22 – Just Published

    Read the latest news and developments – a comprehensive round-up from the Hebrew University and the British Friends.

    Read more
  • Sep142021

    Largest Population-based Study of “Lazy Eye” Reveals Public Health’s Blind Spots

    An estimated 1% to 5% of children worldwide have lazy eye – a childhood condition where the vision does not develop properly.

    Read more
  • Sep072021

    Neurons are much smarter than we thought

    New research at the Hebrew University of Jerusalem (HU) seeks to understand the computing power of a neuron in a systematic manner.

    Read more
  • Aug232021

    Clinical Results Show Tricor (Fenofibrate) Effective in Treating Severe Covid-19 Patients

    Hebrew University study shows lipid-lowering drug reduced inflammation in 48 hours and removed the need for oxygen support within 5 to 7 days for hospitalized COVID-19 patients.

    Read more